Word

SUZHOU FUSE BIOSCIENCES

Status

Dead

Status Code

602

Status Date

Tuesday, January 10, 2023

Serial Number

97021067

Mark Type

4000

Filing Date

Friday, September 10, 2021

Abandoned Date

Wednesday, December 28, 2022

Trademark Owner History

Suzhou Fuse Biosciences Limited

Classifications

5 Therapeutic agents and preparations consisting primarily of biochemicals, immunoglobulin, antigen-binding fragments and cytokines for use in cancer therapies or immunotherapies; preparations and substances for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of locoregionally active cytokines for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of oncology for medical purposes

42 Scientific research and development in the field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; medical and scientific research and development for agents, preparations, products and technology in the field of immunocytokines; providing medical and scientific research information field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; scientific investigations for medical purposes; medical research; providing scientific and medical research information and analysis relating therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines for medical purposes; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; research, design and development of assays for measuring, monitoring, testing and analyzing antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services

Trademark Events

Dec 13, 2023

Teas Change Of Correspondence Received

Dec 13, 2023

Teas Change Of Domestic Representatives Address

Dec 13, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

Dec 13, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Jan 10, 2023

Abandonment Notice E-Mailed - Failure To Respond

Jan 10, 2023

Abandonment Notice Mailed - Failure To Respond

Jan 10, 2023

Abandonment - Failure To Respond Or Late Response

Jun 27, 2022

Notification Of Non-Final Action E-Mailed

Jun 27, 2022

Non-Final Action E-Mailed

Jun 27, 2022

Non-Final Action Written

Jun 15, 2022

Assigned To Examiner

Oct 19, 2021

New Application Office Supplied Data Entered

Sep 14, 2021

New Application Entered